To view the PDF file, sign up for a MySharenet subscription.

AFROCENTRIC INVESTMENT CORPORATION LIMITED - Dealing in securities by a Director of a Major Subsidiary

Release Date: 02/05/2024 16:30
Code(s): ACT     PDF:  
Wrap Text
Dealing in securities by a Director of a Major Subsidiary

AfroCentric Investment Corporation Limited
(Incorporated in the Republic of South Africa)
(Registration number 1988/000570/06)
JSE Code: ACT ISIN: ZAE000078416
("the Company" or "AfroCentric")


Dealing in securities by a Director of a Major Subsidiary

In compliance with the terms of paragraphs 3.63 to 3.74 of the JSE Limited Listings
Requirements, the Company hereby discloses the following director's dealings in AfroCentric
shares relating to the acceptance of awards of shares in terms of the AfroCentric Forfeitable
Share Scheme, adopted by AfroCentric at the annual general meeting held on 10 November
2022 (the "AfroCentric Forfeitable Share Scheme"):

Name of Director:                         Andrew Schwulst
Designation:                              Chief Executive Officer of Medscheme Holdings
                                          Proprietary Limited
Date of transaction:                      25 April 2024
Class of securities:                      Ordinary shares
Number of securities obtained:            1 215 805
Value of transaction:                     R3 999 998.45
Price per security:                       R3.29
Nature of transaction:                    Off-market acceptance of an award of shares in
                                          terms of the AfroCentric Forfeitable Share Scheme
Nature of interest:                       Direct beneficial
Date of vesting of award:                 1 November 2026
Clearance obtained:                       Yes


Johannesburg
2 May 2024

JSE Sponsor to AfroCentric
Questco Corporate Advisory Proprietary Limited

Date: 02-05-2024 04:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story